Chemo-enzymatic process for the preparation of escitalopram

Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Preparing heterocyclic carbon compound having only o – n – s,...

Reexamination Certificate

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C435S128000, C549S467000

Reexamination Certificate

active

07470526

ABSTRACT:
A process for preparing an intermediate for synthesizing escitalopram and the pharmaceutically acceptable salts thereof from 4-(4-dimethylamino)-1-(4′-fluorophenyl)-1-(hydroxybutyl)-3-(acyloxymethyl)benzonitrile is described. The process involves converting said intermediate into the (S+) enantiomer of citalopram by means of enzymatic enantiomeric resolution.

REFERENCES:
patent: 4136193 (1979-01-01), Bogeso et al.
patent: 4650884 (1987-03-01), Bogeso
patent: 6365747 (2002-04-01), Dall'Asta et al.
patent: 2003/0060641 (2003-03-01), Petersen et al.
patent: 0 171 943 (1988-11-01), None
patent: 0 501 310 (1992-09-01), None
patent: 0 347 066 (1995-03-01), None
patent: WO 03/000672 (2003-01-01), None
patent: WO 03/006449 (2003-01-01), None
patent: WO 03/051861 (2003-06-01), None
patent: WO 2004/014821 (2004-02-01), None
Solares et al.,Tetrahedron Assymetry, 15(2):341-345 (2004).

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

Chemo-enzymatic process for the preparation of escitalopram does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Chemo-enzymatic process for the preparation of escitalopram, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Chemo-enzymatic process for the preparation of escitalopram will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-4042762

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.